Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROSUVASTATIN: Safety Overview

Metric ROFLUMILAST ROSUVASTATIN
Total FAERS Reports 2,700 36,332
Deaths Reported 645 1,536
Death Rate 23.9% 4.2%
Hospitalizations 625 11,195
Average Patient Age 68.8 yrs 66.1 yrs
% Female Patients 56.3% 54.9%
FDA Approval Date Apr 17, 2023 Apr 1, 2020
Manufacturer Aurobindo Pharma Limited Umedica Laboratories USA Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription